Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo.Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus. Its biomarkers include C-reactive protein, PHE/Phenylalanine for PKU patients, and Sars-CoV-2/Influenza multiplex tests. The company was incorporated in 2019 and is based in Helsingborg, Sweden.
Stock data | 2024 | Change |
---|---|---|
Price | $0.26394319312171916 | N/A |
Market Cap | $170.39M | N/A |
Shares Outstanding | 645.56M | N/A |
Employees | 13.00 | N/A |